Published in J Exp Med on October 01, 1973
Evidence for the expression of Ia (H-2-associated) antigens on thymus-derived lymphocytes. J Exp Med (1974) 3.56
Analysis of H-2 and Ia molecules by two-dimensional gel electrophoresis. J Exp Med (1977) 3.26
Effects of anti-Ia sera on mitogenic responses. II. Differential expression of the Ia marker on phytohemagglutinin and concanavalin A-reactive T cells. J Exp Med (1976) 2.12
Induction of cytotoxic T lymphocytes against I-region-coded determinants: in vitro evidence for a third histocompatibility locus in the mouse. J Exp Med (1975) 2.09
The presence of I-region-associated antigens on B cells in molecules distinct from immunoglobulin and H-2K and H-2D. Proc Natl Acad Sci U S A (1974) 1.31
I-region genes are expressed on T and B lymphocytes. Studies of the mixed lymphocyte reaction (MLR). J Exp Med (1974) 1.27
Immune responses in vitro. XI. Suppression of primary IgM and IgG plaque-forming cell responses in vitro by alloantisera against leukocyte alloantigens. J Exp Med (1974) 1.24
T-cell-specific murine Ia antigens: serology of I-J and I-E subregion specificities. J Exp Med (1978) 1.12
Antibodies to human caudate nucleus neurons in Huntington's chorea. J Clin Invest (1977) 1.04
The major histocompatibility complex--comparison in the mouse, man, and the rat. A review. Am J Pathol (1978) 0.87
Ontogeny of B lymphocytes. 3. H-2 linkage of a gene controlling the rate of appearance of complement receptor lymphocytes. J Exp Med (1974) 0.87
Partial chemical characterization of Ia antigens derived from murine thymocytes. Proc Natl Acad Sci U S A (1977) 0.84
Alloantiserum-induced inhibition of immune response gene product function. I. Cellular distribution of target antigens. J Exp Med (1974) 0.79
Conversion of immune response patterns from high to low and low to high by an RNase-sensitive thymocyte extract. Immunology (1980) 0.75
Histocompatibility-linked immune response genes. Science (1972) 16.79
Serological identification of an Ir-region product. Science (1973) 3.32
Genetic and immunological complexity of major histocompatibility regions. Science (1972) 2.40
Association of H-2 types with genetic control of immune reponsiveness to IgG (gamma2a) allotypes in the mouse. J Exp Med (1972) 1.71
Graft versus host reaction in strains of mice identical for H-2K and H-2D antigens. Nat New Biol (1973) 1.61
The H-2 system: past and present. Transplant Proc (1973) 1.42
Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell (1994) 9.51
On the thymus in the differentiation of "H-2 self-recognition" by T cells: evidence for dual recognition? J Exp Med (1978) 9.51
A procedure for rapid and sensitive staining of protein fractionated by polyacrylamide gel electrophoresis. Anal Biochem (1967) 7.96
Management of spontaneous pneumothorax: an American College of Chest Physicians Delphi consensus statement. Chest (2001) 5.94
The major histocompatibility complex of the mouse. Science (1979) 4.76
Serologically defined and lymphocyte-defined components of the major histocompatibility complex in the mouse. J Exp Med (1972) 4.59
Generation of protein-reactive antibodies by short peptides is an event of high frequency: implications for the structural basis of immune recognition. Proc Natl Acad Sci U S A (1983) 4.56
Protein iodination with solid state lactoperoxidase. Biochemistry (1974) 4.52
Divergence time and population size in the lineage leading to modern humans. Theor Popul Biol (1995) 4.31
The lymphoreticular system in triggering virus plus self-specific cytotoxic T cells: evidence for T help. J Exp Med (1978) 4.27
Genetic control of the immune response. Mapping of the Ir-1 locus. J Exp Med (1972) 3.96
Electrophoretic heterogeneity of polypeptide chains of specific antibodies. Science (1966) 3.88
The H-2 model for the major histocompatibility systems. Transplant Rev (1971) 3.82
List of congenic lines of mice. I. Lines with differences at alloantigen loci. Transplantation (1973) 3.73
Bracteomania, an inflorescence anomaly, is caused by the loss of function of the MADS-box gene squamosa in Antirrhinum majus. EMBO J (1992) 3.60
Cell-mediated lympholysis. Importance of serologically defined H-2 regions. J Exp Med (1973) 3.34
Serological identification of an Ir-region product. Science (1973) 3.32
The traditional and a new version of the mouse H-2 complex. Nature (1981) 3.12
Enhancement of sheep red blood cell human lymphocyte rosette formation by the sulfhydryl compound 2-amino ethylisothiouronium bromide. Clin Immunol Immunopathol (1975) 3.11
Effect of topically applied T4 endonuclease V in liposomes on skin cancer in xeroderma pigmentosum: a randomised study. Xeroderma Pigmentosum Study Group. Lancet (2001) 2.79
MHC polymorphism pre-dating speciation. Nature (1988) 2.70
Therapy for acute otitis media. Preference of parents for oral or parenteral antibiotic. Arch Pediatr Adolesc Med (1996) 2.68
H-2 haplotypes, genes and antigens: second listing. II. The H-2 complex. Immunogenetics (1983) 2.62
Pharmacokinetics and adverse effects of amphotericin B in infants and children. J Pediatr (1988) 2.62
Origin of major histocompatibility complex polymorphism: the trans-species hypothesis. Hum Immunol (1987) 2.51
Cytotoxic T cells learn specificity for self H-2 during differentiation in the thymus. Nature (1978) 2.51
The polymer mat: arrested rebound of a compressed polymer layer. Eur Phys J E Soft Matter (2002) 2.43
Phylogeny of Darwin's finches as revealed by mtDNA sequences. Proc Natl Acad Sci U S A (1999) 2.42
Genetic and immunological complexity of major histocompatibility regions. Science (1972) 2.40
Polymorphism and balancing selection at major histocompatibility complex loci. Genetics (1992) 2.34
Directly measured second hand smoke exposure and asthma health outcomes. Thorax (2005) 2.32
Molecular characterisation of the Arabidopsis SBP-box genes. Gene (1999) 2.31
Integrin alpha v beta 3 rescues melanoma cells from apoptosis in three-dimensional dermal collagen. Proc Natl Acad Sci U S A (1994) 2.30
Ir-genes in H-2 regulate generation of anti-viral cytotoxic T cells. Mapping to K or D and dominance of unresponsiveness. J Exp Med (1978) 2.24
Unique glycoprotein-proteoglycan complex defined by monoclonal antibody on human melanoma cells. Proc Natl Acad Sci U S A (1982) 2.21
Socio-economic disparities in preterm birth: causal pathways and mechanisms. Paediatr Perinat Epidemiol (2001) 2.19
Hair concentrations of nicotine and cotinine in women and their newborn infants. JAMA (1994) 2.18
Salt extraction of soluble HL-A antigens. Science (1971) 2.18
Evolution of the major histocompatibility complex. Crit Rev Immunol (1986) 2.16
Essential role of insulin receptor substrate 1 in differentiation of brown adipocytes. Mol Cell Biol (2001) 2.14
Degradation of phenanthrene, fluorene and fluoranthene by pure bacterial cultures. Appl Microbiol Biotechnol (1990) 2.12
H-2 mutations: their genetics and effect on immune functions. Adv Immunol (1978) 2.11
Induction of cytotoxic T lymphocytes against I-region-coded determinants: in vitro evidence for a third histocompatibility locus in the mouse. J Exp Med (1975) 2.09
Separation of 7S gamma-1-globulin, 7S gamma-2-globulin and macroglobulin guinea pig antibodies. Proc Soc Exp Biol Med (1966) 2.08
Expression of tissue factor by melanoma cells promotes efficient hematogenous metastasis. Proc Natl Acad Sci U S A (1992) 2.07
Detection of ganglioside GD2 in tumor tissues and sera of neuroblastoma patients. Cancer Res (1984) 2.01
Nucleotide sequences of chimpanzee MHC class I alleles: evidence for trans-species mode of evolution. EMBO J (1988) 1.98
Systemic exposure to mercaptopurine as a prognostic factor in acute lymphocytic leukemia in children. N Engl J Med (1990) 1.91
Graft-versus-host reactions across different regions of the H-2 complex of the mouse. J Exp Med (1973) 1.87
Isolation of Borrelia burgdorferi from the myocardium of a patient with longstanding cardiomyopathy. N Engl J Med (1990) 1.83
Fluidity of water confined to subnanometre films. Nature (2001) 1.80
Structural studies of murine I-E and human DR antigens. Mol Immunol (1979) 1.79
Tissue distribution of I region-associated antigens in the mouse. J Immunol (1974) 1.76
Production of anti-H-2 antibodies in thymectomized mice. Eur J Immunol (1974) 1.74
DNA archives and our nearest relative: the trichotomy problem revisited. Mol Phylogenet Evol (2000) 1.71
H-2 types of translocation stocks T(2;9)138Ca, T(9;13)-190Ca and an H-2 recombinant. Transplantation (1970) 1.71
Evidence supporting a two-gene model for the H-2 histocompatibility system of the mouse. J Exp Med (1972) 1.70
Transplantation antigens. Adv Immunol (1970) 1.70
Murine Ia and human DR antigens: homology of amino-terminal sequences. Proc Natl Acad Sci U S A (1978) 1.70
Augmentation of antibody dependent cell mediated cytotoxicity following in vivo therapy with recombinant interleukin 2. Cancer Res (1990) 1.69
Downregulation of transcription factor SOX2 in cancer stem cells suppresses growth and metastasis of lung cancer. Br J Cancer (2011) 1.69
Disialoganglioside GD2 on human neuroblastoma cells: target antigen for monoclonal antibody-mediated cytolysis and suppression of tumor growth. Cancer Res (1987) 1.68
Essential role of insulin receptor substrate-2 in insulin stimulation of Glut4 translocation and glucose uptake in brown adipocytes. J Biol Chem (2000) 1.67
Phase I trial of a human-mouse chimeric anti-disialoganglioside monoclonal antibody ch14.18 in patients with refractory neuroblastoma and osteosarcoma. J Clin Oncol (1998) 1.67
Genetics of the major histocompatibility complex: the final act. Annu Rev Immunol (1983) 1.65
Targeted interleukin-2 therapy for spontaneous neuroblastoma metastases to bone marrow. J Natl Cancer Inst (1997) 1.64
Anaesthesia in haemodynamically compromised emergency patients: does ketamine represent the best choice of induction agent? Anaesthesia (2009) 1.64
Natural killer cell-mediated eradication of neuroblastoma metastases to bone marrow by targeted interleukin-2 therapy. Blood (1998) 1.64
Daclizumab phase II trial in relapsing and remitting multiple sclerosis: MRI and clinical results. Neurology (2007) 1.63
A phase I/IB trial of murine monoclonal anti-GD2 antibody 14.G2a plus interleukin-2 in children with refractory neuroblastoma: a report of the Children's Cancer Group. Cancer (1997) 1.63
Polymorphism of the mouse H-2 loci. Immunol Rev (1981) 1.63
Determination of gestational cocaine exposure by hair analysis. JAMA (1989) 1.63
Natural history of left ventricular thrombi: their appearance and resolution in the posthospitalization period of acute myocardial infarction. J Am Coll Cardiol (1990) 1.61
Graft versus host reaction in strains of mice identical for H-2K and H-2D antigens. Nat New Biol (1973) 1.61
A phase I study of human/mouse chimeric antiganglioside GD2 antibody ch14.18 in patients with neuroblastoma. Eur J Cancer (1995) 1.59
Acute changes in renal function associated with deferoxamine therapy. Am J Dis Child (1989) 1.59
The origin and age of haplochromine fishes in Lake Victoria, east Africa. Proc Biol Sci (2000) 1.59
Intensity of natural selection at the major histocompatibility complex loci. Proc Natl Acad Sci U S A (1994) 1.59
In irradiation chimeras, K or D regions of the chimeric host, not of the donor lymphocytes, determine immune responsiveness of antiviral cytotoxic T cells. J Exp Med (1978) 1.57
A rapid method for direct HL-A typing of cultured lymphoid cells. J Immunol (1971) 1.55
Private and public antigens of the mouse H-2 system. Nature (1971) 1.53
Antibody-targeted interleukin 2 stimulates T-cell killing of autologous tumor cells. Proc Natl Acad Sci U S A (1992) 1.51
Characterization of Ia antigens in mouse serum. J Immunol (1976) 1.51
Structure of the murine Ia-associated invariant (Ii) chain as deduced from a cDNA clone. EMBO J (1984) 1.51
Cytological identification of the chromosome carrying the IXth linkage group (including H-2) in the house mouse. Proc Natl Acad Sci U S A (1971) 1.51
Human neural cell adhesion molecule L1 and rat homologue NILE are ligands for integrin alpha v beta 3. J Cell Biol (1996) 1.50
Responder T cells depleted of alloreactive cells react to antigen presented on allogeneic macrophages from nonresponder strains. J Exp Med (1981) 1.49
Hostility and myocardial ischemia in coronary artery disease patients: evaluation by gender and ischemic index. Psychosom Med (1993) 1.48
Effect of a chimeric anti-ganglioside GD2 antibody on cell-mediated lysis of human neuroblastoma cells. Cancer Res (1991) 1.48
Transplantation of highly purified CD34+Thy-1+ hematopoietic stem cells in patients with metastatic breast cancer. Biol Blood Marrow Transplant (2000) 1.48
Borrelia burgdorferi as an etiologic agent in chronic heart failure? Scand J Infect Dis Suppl (1991) 1.48
Antigens associated with a human lung adenocarcinoma defined by monoclonal antibodies. Cancer Res (1984) 1.48
On the origin of Darwin's finches. Mol Biol Evol (2001) 1.46
Primary in vitro cell-mediated lympholysis reaction of NZB mice against unmodified targets syngeneic at the major histocompatibility complex. J Exp Med (1978) 1.45
Functional properties and effect on growth suppression of human neuroblastoma tumors by isotype switch variants of monoclonal antiganglioside GD2 antibody 14.18. Cancer Res (1989) 1.45
Genetic organization and evolution of the mouse H-2 region: a duplication model. Transplant Proc (1971) 1.44
An Arg-Gly-Asp-directed receptor on the surface of human melanoma cells exists in an divalent cation-dependent functional complex with the disialoganglioside GD2. J Cell Biol (1987) 1.44
Congenic mouse strains with different immunoglobulin allotypes. I. Breeding scheme, histocompatibility tests, and kinetics of gamma G2a-globulin production by transferred cells for C3H.SW and its congenic partner CWB/5. Transplantation (1967) 1.44